US Senators urge Health and Human Services to monitor assisted suicide.

Alex Schadenberg
Executive Director, Euthanasia Prevention Coalition

Senator James Lankford

There are now 13 US states as well as Washington DC that have legalized assisted suicide. A press release from US Senators James Lankford (R-OK) and Tim Kaine (D-VA) to Health and Human Services  (HHS) Secretary Robert F. Kennedy, Jr. urging HHS and the Centers for Medicare & Medicaid Services (CMS) urges them:

to establish reporting requirements in the hospice program to monitor physician-assisted suicide for discrimination against individuals with disabilities, older adults, and other vulnerable populations.

The letter warned Secretary Kennedy that assisted suicide:

“raises significant informed consent issues as well as concerns about disability and age discrimination” and noted that the vast majority of patients receiving physician-assisted suicide are enrolled in hospice.

Senator Tim Kaine

The Senators further stated:

“We urge HHS and CMS to establish reporting requirements to monitor physician-assisted suicide for discriminatory practices and oversee compliance with federal funding restrictions within hospice programs. All hospice patients—regardless of disability, age or financial means—deserve compassionate end-of-life care that is free of coercion and discrimination.”

The Senators were joined by US Representatives Greg Murphy, M.D. (R-NC-03) and Lou Correa (D-CA-46).

Link to the letter to Health and Human Services Secretary Robert F. Kennedy (Letter Link).

Rep Greg Murphy

The Euthanasia Prevention Coalition (EPC) shares the concerns of Senators Lankford and Kaine and Representatives Murphy and Correa. We are particularly concerned with the formulation and use of poison drug cocktails for assisted suicide that are not approved as "safe" by The Food and Drug Administration (FDA).

The letter from the Senators and Representatives states:

Physician-assisted suicide drugs are not approved for the purpose of ending human life. The Food and Drug Administration (FDA) has not approved drugs indicated for physician-assisted suicide. These drugs would not meet the criteria as "safe" for the purposes of the Federal Food, Drug, and Cosmetic Act. Instead, medical practitioners prescribe drugs approved for other indications to be used "off-label" for physician-assisted suicide. As the Atlantic reported in 2019, "[I]n states where the practice is legal, state governments provide guidance about which patients qualify but say nothing about which drugs to prescribe." With "no government-approved clinical drug trial, and no Institutional Review Board oversight," physician-assisted suicide drug prescribers are left with little oversight in assisting end-of-life patients"

Rep Lou Correa

EPC is also very concerned about abuses related to the Assisted Suicide Funding Restrictions Act that essentially restricts federal funding for assisted suicide and protects the conscience rights for medical practitioners who object to assisted suicide. The letter from the letter from the Senators and Representatives states:

We request that you establish reporting requirements within hospice programs regarding physician-assisted suicide. In doing so, please consider monitoring physician-assisted suicide practises for the following:

• Discrimination against individuals with disabilities, older adults, and other vulnerable populations; 

• Proper disposal of unused medication and prevention of drug diversion; 

• Insurance denials of life-sustaining medical care that offer to cover physician-assisted suicide drugs instead.

There are many concerns with assisted suicide laws and the practise of assisting suicides. Some of the key issues include the lack of clear oversight and the use of lethal poison drug cocktails. The drug cocktails are concerning for their use but also the abuse the occurred with their experimental development.